Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - repaglinide - tablet - 2mg

USA - engelsk - NLM (National Library of Medicine)

carilion materials management - repaglinide (unii: 668z8c33lu) (repaglinide - unii:668z8c33lu) - repaglinide 0.5 mg - prandin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. limitation of use: prandin should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. prandin is contraindicated in patients with: pregnancy category c. there are no adequate and well-controlled studies in pregnant women. it is unknown whether prandin can cause fetal harm when administered to a pregnant woman. prandin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. repaglinide was not teratogenic in rats or rabbits at doses 40 times (rats) and approximately 0.8 times (rabbit) clinical exposure (on a mg/m2 basis) throughout pregnancy. offspring of rat dams exposed to repaglinide at 15 times clinical exposure on a mg/m2 basis during days 17 to 22 of gestation and during lactation developed nonteratogenic skeletal deformities consisting of shortening, thickening, and bending of the h

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - repaglinide 1mg - tablet - 1 mg - active: repaglinide 1mg excipient: calcium hydrogen phosphate glycerol magnesium stearate maize starch meglumine microcrystalline cellulose polacrilin potassium poloxamer 188 povidone purified water

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution - repaglinide - tablet - 2mg

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - repaglinide - tablet - 2mg

Malta - engelsk - Medicines Authority

actavis group ptc ehf - repaglinide - tablet - repaglinide 1 mg - drugs used in diabetes

USA - engelsk - NLM (National Library of Medicine)

gemini laboratories, llc - repaglinide (unii: 668z8c33lu) (repaglinide - unii:668z8c33lu) - repaglinide 2 mg in 1 mg

Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - repaglinide 0,5 mg - tablet - 0,5 mg - repaglinide 0.5 mg - repaglinide

Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - repaglinide 2 mg - tablet - 2 mg - repaglinide 2 mg - repaglinide

Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - repaglinide 0,5 mg - tablet - 0,5 mg - repaglinide 0.5 mg - repaglinide